These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
198 related items for PubMed ID: 12607599
1. Immunohistochemical expression of basic fibroblast growth factor, vascular endothelial growth factor, and their receptors in stage IV non-Hodgkin lymphoma. Ho CL, Sheu LF, Li CY. Appl Immunohistochem Mol Morphol; 2002 Dec; 10(4):316-21. PubMed ID: 12607599 [Abstract] [Full Text] [Related]
2. Immunohistochemical expression of angiogenic cytokines and their receptors in reactive benign lymph nodes and non-Hodgkin lymphoma. Ho CL, Sheu LF, Li CY. Ann Diagn Pathol; 2003 Feb; 7(1):1-8. PubMed ID: 12616467 [Abstract] [Full Text] [Related]
3. Vascular endothelial growth factor and basic fibroblast growth factor present in Kaposi's sarcoma (KS) are induced by inflammatory cytokines and synergize to promote vascular permeability and KS lesion development. Samaniego F, Markham PD, Gendelman R, Watanabe Y, Kao V, Kowalski K, Sonnabend JA, Pintus A, Gallo RC, Ensoli B. Am J Pathol; 1998 Jun; 152(6):1433-43. PubMed ID: 9626048 [Abstract] [Full Text] [Related]
4. VEGF and bFGF are highly expressed in intraluminal fibromyxoid lesions in bronchiolitis obliterans organizing pneumonia. Lappi-Blanco E, Soini Y, Kinnula V, Pääkkö P. J Pathol; 2002 Feb; 196(2):220-7. PubMed ID: 11793374 [Abstract] [Full Text] [Related]
5. Significance of vessel count and vascular endothelial growth factor and its receptor (KDR) in intestinal-type gastric cancer. Takahashi Y, Cleary KR, Mai M, Kitadai Y, Bucana CD, Ellis LM. Clin Cancer Res; 1996 Oct; 2(10):1679-84. PubMed ID: 9816116 [Abstract] [Full Text] [Related]
6. Levels of vascular endothelial growth factor, hepatocyte growth factor/scatter factor and basic fibroblast growth factor in human gliomas and their relation to angiogenesis. Schmidt NO, Westphal M, Hagel C, Ergün S, Stavrou D, Rosen EM, Lamszus K. Int J Cancer; 1999 Feb 19; 84(1):10-8. PubMed ID: 9988225 [Abstract] [Full Text] [Related]
7. Bone marrow immunohistochemical studies of angiogenic cytokines and their receptors in myelofibrosis with myeloid metaplasia. Chou JM, Li CY, Tefferi A. Leuk Res; 2003 Jun 19; 27(6):499-504. PubMed ID: 12648509 [Abstract] [Full Text] [Related]
9. Expression patterns of angiogenic and lymphangiogenic factors in ductal breast carcinoma in situ. Wülfing P, Kersting C, Buerger H, Mattsson B, Mesters R, Gustmann C, Hinrichs B, Tio J, Böcker W, Kiesel L. Br J Cancer; 2005 May 09; 92(9):1720-8. PubMed ID: 15841074 [Abstract] [Full Text] [Related]
10. Vascular endothelial growth factor (VEGF) receptor-2 antagonists inhibit VEGF- and basic fibroblast growth factor-induced angiogenesis in vivo and in vitro. Tille JC, Wood J, Mandriota SJ, Schnell C, Ferrari S, Mestan J, Zhu Z, Witte L, Pepper MS. J Pharmacol Exp Ther; 2001 Dec 09; 299(3):1073-85. PubMed ID: 11714897 [Abstract] [Full Text] [Related]
11. [Expression of vascular endothelial growth factor and its receptors in endometrial carcinoma]. Wang H, Chen G, Zhang B. Zhonghua Bing Li Xue Za Zhi; 2002 Oct 09; 31(5):391-5. PubMed ID: 12485477 [Abstract] [Full Text] [Related]
12. [Study of the changes and effect of VEGF and bFGF in early stage of maxillofacial blast injury in rabbits]. Zhang C, Li H, Zhou S, Yang J. Hua Xi Kou Qiang Yi Xue Za Zhi; 2001 Apr 09; 19(2):77-9, 82. PubMed ID: 12539415 [Abstract] [Full Text] [Related]
13. Expression of vascular endothelial growth factor in lymphomas and Castleman's disease. Foss HD, Araujo I, Demel G, Klotzbach H, Hummel M, Stein H. J Pathol; 1997 Sep 09; 183(1):44-50. PubMed ID: 9370946 [Abstract] [Full Text] [Related]
14. Angiogenesis and mast cells in non-Hodgkin's lymphoma: a strong correlation in angioimmunoblastic T-cell lymphoma. Fukushima N, Satoh T, Sano M, Tokunaga O. Leuk Lymphoma; 2001 Aug 09; 42(4):709-20. PubMed ID: 11697501 [Abstract] [Full Text] [Related]
15. Correlation of bFGF, FGFR-1 and VEGF expression with vascularity and malignancy of human astrocytomas. Bian XW, Du LL, Shi JQ, Cheng YS, Liu FX. Anal Quant Cytol Histol; 2000 Jun 09; 22(3):267-74. PubMed ID: 10872046 [Abstract] [Full Text] [Related]
16. Angiogenic and lymphangiogenic molecules in hematological malignancies. Orpana A, Salven P. Leuk Lymphoma; 2002 Feb 09; 43(2):219-24. PubMed ID: 11999550 [Abstract] [Full Text] [Related]
17. Localization of vascular endothelial growth factor and its receptors in digestive endocrine tumors: correlation with microvessel density and clinicopathologic features. La Rosa S, Uccella S, Finzi G, Albarello L, Sessa F, Capella C. Hum Pathol; 2003 Jan 09; 34(1):18-27. PubMed ID: 12605362 [Abstract] [Full Text] [Related]
18. Expression of vascular endothelial growth factor (VEGF) and its receptors (Flt-1 and Flk-1) in esophageal squamous cell carcinoma. Kato H, Yoshikawa M, Miyazaki T, Nakajima M, Fukai Y, Masuda N, Fukuchi M, Manda R, Tsukada K, Kuwano H. Anticancer Res; 2002 Jan 09; 22(6C):3977-84. PubMed ID: 12553021 [Abstract] [Full Text] [Related]
19. Angiogenesis in fetal tendon development: spatial and temporal expression of the angiogenic peptide vascular endothelial cell growth factor. Petersen W, Pufe T, Kurz B, Mentlein R, Tillmann B. Anat Embryol (Berl); 2002 Jul 09; 205(4):263-70. PubMed ID: 12136256 [Abstract] [Full Text] [Related]
20. Simultaneous elevation in the serum concentrations of the angiogenic growth factors VEGF and bFGF is an independent predictor of poor prognosis in non-Hodgkin lymphoma: a single-institution study of 200 patients. Salven P, Orpana A, Teerenhovi L, Joensuu H. Blood; 2000 Dec 01; 96(12):3712-8. PubMed ID: 11090051 [Abstract] [Full Text] [Related] Page: [Next] [New Search]